Compare $RCEL vs $SCTX | Chartloom

Compare

$RCEL vs $SCTX

AVITA Medical Inc · Scribe Therapeutics Inc

RCEL

AVITA Medical Inc

SCTX

Scribe Therapeutics Inc

Compare $RCEL vs $SCTX

Comparing AVITA Medical Inc and Scribe Therapeutics Inc

RCELAVITA Medical Inc

SCTXScribe Therapeutics Inc

RCELAVITA Medical Inc

Market cap

$407M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

4.05x

Rev growth (TTM)

1.0%

YTD performance

280.7%

52W performance

139.7%

FCF yield

-6.2%

SCTXScribe Therapeutics Inc

Market cap

$372M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

29.61x

Rev growth (TTM)

—

YTD performance

-2.2%

52W performance

-2.2%

FCF yield

0.0%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

RCEL

SCTX

Detailed metrics comparison

RCEL

AVITA Medical Inc

SCTX

Scribe Therapeutics Inc

Market Cap

RCEL$407M

SCTX$372M

Enterprise Value

RCEL$444M

SCTX$374M

Price

RCEL$13.21

SCTX$21.17

P/E Ratio

RCELN/A

SCTXN/A

P/S Ratio

RCEL5.38x

SCTX0.00x

EV/Sales

RCEL5.87x

SCTX0.00x

EV/EBITDA

RCEL0.00x

SCTX0.00x

P/B Ratio

RCEL87.44x

SCTXN/A

P/FCF Ratio

RCELN/A

SCTXN/A

EV/FCF

RCEL-17.54x

SCTX0.00x

PEG Ratio

RCELN/A

SCTXN/A

Forward P/E (NTM)

RCELN/A

SCTXN/A

Forward P/S (NTM)

RCEL4.05x

SCTX29.61x

Revenue (TTM)

RCEL$76M

SCTX$0

Revenue Growth (YoY)

RCEL1.0%

SCTXN/A

Forward Rev Growth

RCEL20.3%

SCTX-43.3%

Gross Margin (TTM)

RCEL82.1%

SCTX0.0%

Operating Margin (TTM)

RCEL0.0%

SCTX0.0%

EBITDA Margin (TTM)

RCEL-41.9%

SCTX0.0%

Net Margin (TTM)

RCEL-57.0%

SCTX0.0%

FCF Margin (TTM)

RCEL-33.5%

SCTXN/A

Net Income (TTM)

RCEL$-43M

SCTXN/A

FCF (TTM)

RCEL$-25M

SCTX$0

EPS (TTM)

RCEL-$1.40

SCTX$0.00

ROE (TTM)

RCEL-33790.0%

SCTX0.0%

ROA (TTM)

RCEL-7853.0%

SCTX0.0%

ROIC (TTM)

RCEL-10295.0%

SCTX0.0%

Cash

RCEL$9M

SCTX$36M

Debt

RCEL$47M

SCTX$38M

Net Cash/Debt

RCEL$-38M

SCTX$-2M

Current Ratio (TTM)

RCEL0.41x

SCTX0.57x

Quick Ratio (TTM)

RCEL0.31x

SCTX0.56x

Debt/Equity (TTM)

RCEL9.39x

SCTX0.00x

Debt/Assets (TTM)

RCEL0.0%

SCTX0.0%

Interest Coverage (TTM)

RCELN/A

SCTXN/A

Net Debt/EBITDA (TTM)

RCEL0.00x

SCTX0.00x

Beta

RCEL2.07

SCTX-2.64

52W Performance

RCEL139.7%

SCTX-2.2%

YTD Performance

RCEL280.7%

SCTX-2.2%

% from 52W High

RCEL-3.7%

SCTX-46.5%

% from 52W Low

RCEL310.2%

SCTX56.8%

Asset Turnover (TTM)

RCEL1.38x

SCTX0.00x

FCF Yield (TTM)

RCEL-6.2%

SCTX0.0%

Earnings Yield (TTM)

RCEL-10.6%

SCTX0.0%

Dividend Yield (TTM)

RCELN/A

SCTXN/A

Rule of 40

RCEL-32.5

SCTX0.0

EV/GP/RG

RCEL0.22

SCTXN/A

Ticker research

View RCEL research View SCTX research

Metric	RCEL AVITA Medical Inc	SCTX Scribe Therapeutics Inc
Market & Valuation
Market Cap	$407M	$372M
Enterprise Value	$444M	$374M
Price	$13.21	$21.17
P/E Ratio	N/A	N/A
P/S Ratio	5.38x	0.00x
EV/Sales	5.87x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	87.44x	N/A
P/FCF Ratio	N/A	N/A
EV/FCF	-17.54x	0.00x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	4.05x	29.61x
Revenue & Growth
Revenue (TTM)	$76M	$0
Revenue Growth (YoY)	1.0%	N/A
Forward Rev Growth	20.3%	-43.3%
Profitability
Gross Margin (TTM)	82.1%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-41.9%	0.0%
Net Margin (TTM)	-57.0%	0.0%
FCF Margin (TTM)	-33.5%	N/A
Net Income (TTM)	$-43M	N/A
FCF (TTM)	$-25M	$0
EPS (TTM)	-$1.40	$0.00
ROE (TTM)	-33790.0%	0.0%
ROA (TTM)	-7853.0%	0.0%
ROIC (TTM)	-10295.0%	0.0%
Financial Health
Cash	$9M	$36M
Debt	$47M	$38M
Net Cash/Debt	$-38M	$-2M
Current Ratio (TTM)	0.41x	0.57x
Quick Ratio (TTM)	0.31x	0.56x
Debt/Equity (TTM)	9.39x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.07	-2.64
52W Performance	139.7%	-2.2%
YTD Performance	280.7%	-2.2%
% from 52W High	-3.7%	-46.5%
% from 52W Low	310.2%	56.8%
Efficiency & Yields
Asset Turnover (TTM)	1.38x	0.00x
FCF Yield (TTM)	-6.2%	0.0%
Earnings Yield (TTM)	-10.6%	0.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-32.5	0.0
EV/GP/RG	0.22	N/A
Ticker research	View RCEL research	View SCTX research

Valuation

P/S Ratio

SCTX

0.00x

RCEL

5.38x

EV/FCF

RCEL

-17.54x

SCTX

0.00x

Growth & revenue

Revenue Growth TTM

RCEL

1.0%

Forward Revenue Growth

RCEL

20.3%

SCTX

-43.3%

Profitability & performance

Gross Margin

RCEL

82.1%

SCTX

0.0%

ROE

SCTX

0.0%

RCEL

-33790.0%

FCF Yield %

SCTX

0.0%

RCEL

-6.2%

52-Week Performance

RCEL

139.7%

SCTX

-2.2%

Detailed metrics comparison

RCEL

AVITA Medical Inc

SCTX

Scribe Therapeutics Inc

Market Cap

RCEL$407M

SCTX$372M

Enterprise Value

RCEL$444M

SCTX$374M

Price

RCEL$13.21

SCTX$21.17

P/E Ratio

RCELN/A

SCTXN/A

P/S Ratio

RCEL5.38x

SCTX0.00x

EV/Sales

RCEL5.87x

SCTX0.00x

EV/EBITDA

RCEL0.00x

SCTX0.00x

P/B Ratio

RCEL87.44x

SCTXN/A

P/FCF Ratio

RCELN/A

SCTXN/A

EV/FCF

RCEL-17.54x

SCTX0.00x

PEG Ratio

RCELN/A

SCTXN/A

Forward P/E (NTM)

RCELN/A

SCTXN/A

Forward P/S (NTM)

RCEL4.05x

SCTX29.61x

Revenue (TTM)

RCEL$76M

SCTX$0

Revenue Growth (YoY)

RCEL1.0%

SCTXN/A

Forward Rev Growth

RCEL20.3%

SCTX-43.3%

Gross Margin (TTM)

RCEL82.1%

SCTX0.0%

Operating Margin (TTM)

RCEL0.0%

SCTX0.0%

EBITDA Margin (TTM)

RCEL-41.9%

SCTX0.0%

Net Margin (TTM)

RCEL-57.0%

SCTX0.0%

FCF Margin (TTM)

RCEL-33.5%

SCTXN/A

Net Income (TTM)

RCEL$-43M

SCTXN/A

FCF (TTM)

RCEL$-25M

SCTX$0

EPS (TTM)

RCEL-$1.40

SCTX$0.00

ROE (TTM)

RCEL-33790.0%

SCTX0.0%

ROA (TTM)

RCEL-7853.0%

SCTX0.0%

ROIC (TTM)

RCEL-10295.0%

SCTX0.0%

Cash

RCEL$9M

SCTX$36M

Debt

RCEL$47M

SCTX$38M

Net Cash/Debt

RCEL$-38M

SCTX$-2M

Current Ratio (TTM)

RCEL0.41x

SCTX0.57x

Quick Ratio (TTM)

RCEL0.31x

SCTX0.56x

Debt/Equity (TTM)

RCEL9.39x

SCTX0.00x

Debt/Assets (TTM)

RCEL0.0%

SCTX0.0%

Interest Coverage (TTM)

RCELN/A

SCTXN/A

Net Debt/EBITDA (TTM)

RCEL0.00x

SCTX0.00x

Beta

RCEL2.07

SCTX-2.64

52W Performance

RCEL139.7%

SCTX-2.2%

YTD Performance

RCEL280.7%

SCTX-2.2%

% from 52W High

RCEL-3.7%

SCTX-46.5%

% from 52W Low

RCEL310.2%

SCTX56.8%

Asset Turnover (TTM)

RCEL1.38x

SCTX0.00x

FCF Yield (TTM)

RCEL-6.2%

SCTX0.0%

Earnings Yield (TTM)

RCEL-10.6%

SCTX0.0%

Dividend Yield (TTM)

RCELN/A

SCTXN/A

Rule of 40

RCEL-32.5

SCTX0.0

EV/GP/RG

RCEL0.22

SCTXN/A

Ticker research

View RCEL research View SCTX research

Metric	RCEL AVITA Medical Inc	SCTX Scribe Therapeutics Inc
Market & Valuation
Market Cap	$407M	$372M
Enterprise Value	$444M	$374M
Price	$13.21	$21.17
P/E Ratio	N/A	N/A
P/S Ratio	5.38x	0.00x
EV/Sales	5.87x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	87.44x	N/A
P/FCF Ratio	N/A	N/A
EV/FCF	-17.54x	0.00x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	4.05x	29.61x
Revenue & Growth
Revenue (TTM)	$76M	$0
Revenue Growth (YoY)	1.0%	N/A
Forward Rev Growth	20.3%	-43.3%
Profitability
Gross Margin (TTM)	82.1%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-41.9%	0.0%
Net Margin (TTM)	-57.0%	0.0%
FCF Margin (TTM)	-33.5%	N/A
Net Income (TTM)	$-43M	N/A
FCF (TTM)	$-25M	$0
EPS (TTM)	-$1.40	$0.00
ROE (TTM)	-33790.0%	0.0%
ROA (TTM)	-7853.0%	0.0%
ROIC (TTM)	-10295.0%	0.0%
Financial Health
Cash	$9M	$36M
Debt	$47M	$38M
Net Cash/Debt	$-38M	$-2M
Current Ratio (TTM)	0.41x	0.57x
Quick Ratio (TTM)	0.31x	0.56x
Debt/Equity (TTM)	9.39x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.07	-2.64
52W Performance	139.7%	-2.2%
YTD Performance	280.7%	-2.2%
% from 52W High	-3.7%	-46.5%
% from 52W Low	310.2%	56.8%
Efficiency & Yields
Asset Turnover (TTM)	1.38x	0.00x
FCF Yield (TTM)	-6.2%	0.0%
Earnings Yield (TTM)	-10.6%	0.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-32.5	0.0
EV/GP/RG	0.22	N/A
Ticker research	View RCEL research	View SCTX research